![](https://unicorn-nest.com/wp-content/uploads/2021/11/Lucion.png?x55332)
In 2000 was created Lucion, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Jinan. The company was established in Asia in China.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. The real fund results show that this Corporate Investor is 40 percentage points more often commits exit comparing to other companies.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Clinical Trials, Digital Media. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight XGIMI, Airwing.ai, Ruiyi Biotechnology (Realbio Technology).
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Lucion, startups are often financed by CrestValue, Chengdu Technology Transfer Group, CDF-Capital. The meaningful sponsors for the fund in investment in the same round are Wuxi Capital, Sichuan Culture Industry Fund, Sailing Capital. In the next rounds fund is usually obtained by Country Garden, Ant Financial.
Related Funds
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Keylights | $15M | 12 Jan 2024 | Shenzhen, Guangdong, China | ||
ACXEL Tech | $15M | 01 Jan 2024 | Foshan, Guangdong, China | ||
CVA Chip | $30M | 13 Nov 2023 | Shenzhen, Guangdong, China | ||
Best Ray | 15 Sep 2023 | Jinan, Shandong, China | |||
Tage Zhixing | $61M | 01 Sep 2023 | Beijing, Beijing, China | ||
Xinhuan Technology | 28 Aug 2023 | Shenzhen, Guangdong, China | |||
Anhui YOFC Advanced Semiconductor | $587M | 28 Jun 2023 | Wuhu, Anhui, China | ||
Jitong Life | 25 Jun 2023 | Suzhou Shi, Jiangsu, China | |||
Jingcai Intelligent | 20 Jun 2023 | Haidian, Beijing, China |
– ABclonal Biotechnology, a global life science tools and services provider, recently completed its $92.9 million Series C financing led by Sequoia Capital China and healthcare-focused investor LYFE Capital.
– Other new and existing shareholders, such as Sigma Square Capital, Kinghall Ventures, and Lucion Capital, participated in the new round.
– ABclonal Biotechnology, parent company of Massachusetts-based life science research and diagnostic reagents manufacturer, ABclonal Technology, will use the additional funding to accelerate the company’s research and development pipeline for in vitro diagnostic raw materials and rapidly expand production capabilities of its research reagent products and services.
– ABclonal is also currently in talks to acquire a contract research organization focused on single-cell-based monoclonal antibody development. This will be the company’s first step toward using the $92.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Keylights | $15M | 12 Jan 2024 | Shenzhen, Guangdong, China | ||
ACXEL Tech | $15M | 01 Jan 2024 | Foshan, Guangdong, China | ||
CVA Chip | $30M | 13 Nov 2023 | Shenzhen, Guangdong, China | ||
Best Ray | 15 Sep 2023 | Jinan, Shandong, China | |||
Tage Zhixing | $61M | 01 Sep 2023 | Beijing, Beijing, China | ||
Xinhuan Technology | 28 Aug 2023 | Shenzhen, Guangdong, China | |||
Anhui YOFC Advanced Semiconductor | $587M | 28 Jun 2023 | Wuhu, Anhui, China | ||
Jitong Life | 25 Jun 2023 | Suzhou Shi, Jiangsu, China | |||
Jingcai Intelligent | 20 Jun 2023 | Haidian, Beijing, China |